ANTI-SENSE OLIGONUCLEOTIDES AS POTENTIAL ANTITUMOUR AGENTS - PROSPECTIVE VIEWS AND PRELIMINARY-RESULTS
- 1 March 1988
- journal article
- research article
- Vol. 2 (4) , 325-331
Abstract
The expression of some proto-oncogenes (c-myc, N-myc, epidermal growth factor receptor) is frequently enhanced in several human malignant tissues. The reduction of level of this expression through the use of anti-sense RNA or anti-sense oligodeoxynucleotides might therefore offer a new way to modify at the somatic level some genetic traits controlled by these oncogenes and possibly related to the maintenance of the transformed phenotype. This approach, although interesting, is paved with considerable conceptual and technical difficulties: multigene involvement in many natural oncogenic processes as well as delivery and stability of the anti-sense nucleic acids. This paper briefly discusses some of these points and presents preliminary results obtained with the .alpha.-anomeric oligodeoxyribonucleotides.This publication has 6 references indexed in Scilit:
- Antisense oligodeoxynucleotides provide insight into mechanism of translation initiation of two Sendai virus mRNAs.Journal of Biological Chemistry, 1987
- Influence of 5' proximal secondary structure on the translational efficiency of eukaryotic mRNAs and on their interaction with initiation factors.Journal of Biological Chemistry, 1986
- UPTAKE, CYTOFLUORESCENCE, AND CYTOTOXICITY OF OXAZOLOPYRIDOCARBAZOLES (AMINO ACID-ELLIPTICINE CONJUGATES) IN MURINE SARCOMA-CELLS1986
- Anti-messenger oligodeoxynucleotides: specific inhibition of rabbit β-globin synthesis in wheat germ extracts and Xenopus oocytesBiochimie, 1986
- Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.Proceedings of the National Academy of Sciences, 1984
- Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.Proceedings of the National Academy of Sciences, 1978